According to a new study, a third dose of the coronavirus vaccine could help boost the antibody levels among some Organ transplant recipients who have not had vigorous responses to the typical vaccination schedules.After the second shot of vaccination, participants who had no assessable antibodies demonstrated a significant rise in antibodies upon completion of the third shot.
Furthermore, the rise is evident amongst at least one-third of the participants. The conclusions were published on Monday in the journal called Annals of Internal Medicine.Organ transplant receivers may not have a suitable response to coronavirus vaccines because they already take drugs and medications to overpower their immune systems. That naturally helps to reduce the risk of the body rejecting new Organ and bound the responses to vaccines.
When pharmacological companies tested the coronavirus vaccines in clinical trials last year, they precisely excluded the people who were taking immune suppressant drugs due to potential risks. But for the Organ transplant patients, after a two-dose full vaccine series, there is an overwhelming majority with either no antibodies or low antibodies, as Segev said.